These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 7558601)

  • 1. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors.
    Domingo GJ; Leatherbarrow RJ; Freeman N; Patel S; Weir M
    Int J Pept Protein Res; 1995 Jul; 46(1):79-87. PubMed ID: 7558601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide mimics of the Bowman-Birk inhibitor protein.
    McBride JD; Leatherbarrow RJ
    Curr Med Chem; 2001 Jul; 8(8):909-17. PubMed ID: 11375759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library.
    McBride JD; Freeman N; Domingo GJ; Leatherbarrow RJ
    J Mol Biol; 1996 Jun; 259(4):819-27. PubMed ID: 8683585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the P2' position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin. Studies on P2' variation in cyclic peptides encompassing the reactive site loop.
    Gariani T; McBride JD; Leatherbarrow RJ
    Biochim Biophys Acta; 1999 Apr; 1431(1):232-7. PubMed ID: 10209295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK; Hinkers SC
    J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino Acid Scanning at P5' within the Bowman-Birk Inhibitory Loop Reveals Specificity Trends for Diverse Serine Proteases.
    Li CY; de Veer SJ; White AM; Chen X; Harris JM; Swedberg JE; Craik DJ
    J Med Chem; 2019 Apr; 62(7):3696-3706. PubMed ID: 30888159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.
    Miles SM; Leatherbarrow RJ; Marsden SP; Coates WJ
    Org Biomol Chem; 2004 Feb; 2(3):281-3. PubMed ID: 14747852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of protease inhibitors based on the Bowman-Birk reactive site loop to hydrolysis by proteases.
    Gariani T; Leatherbarrow RJ
    J Pept Res; 1997 Jun; 49(6):467-75. PubMed ID: 9266473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and primary structure determination of a Bowman-Birk trypsin inhibitor from Torresea cearensis seeds.
    Tanaka AS; Sampaio MU; Marangoni S; de Oliveira B; Novello JC; Oliva ML; Fink E; Sampaio CA
    Biol Chem; 1997; 378(3-4):273-81. PubMed ID: 9165081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
    McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
    J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High molecular weight soy isoinhibitors of the Bowman-Birk type. Isolation, characteristics, and kinetics of interaction with proteinases].
    Gladysheva IP; Sharafutdinov TZ; Larionova NI
    Bioorg Khim; 1994 Mar; 20(3):281-9. PubMed ID: 8166755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
    Marschütz MK; Bernkop-Schnürch A
    Biomaterials; 2000 Jul; 21(14):1499-507. PubMed ID: 10872779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae.
    Terabe M; Kojima S; Taguchi S; Momose H; Miura K
    Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on soybean trypsin inhibitors. X. Isolation and partial characterization of four soybean double-headed proteinase inhibitors.
    Odani S; Ikenaka T
    J Biochem; 1977 Dec; 82(6):1513-22. PubMed ID: 599140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
    Jaulent AM; Leatherbarrow RJ
    Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase inhibition using small Bowman-Birk-type structures.
    Fernandez JH; Mello MO; Galgaro L; Tanaka AS; Silva-Filho MC; Neshich G
    Genet Mol Res; 2007 Oct; 6(4):846-58. PubMed ID: 18058707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor.
    Malykh EV; Larionova NI
    Biochemistry (Mosc); 2002 Dec; 67(12):1383-7. PubMed ID: 12600268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
    Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A; Domoney C
    Curr Protein Pept Sci; 2006 Jun; 7(3):201-16. PubMed ID: 16787260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.